Status:
COMPLETED
Probiotics in Paediatric Asthma Management
Lead Sponsor:
Probiotical S.p.A.
Conditions:
Asthma in Children
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
Randomized controlled double-blind trial in a child population with allergic asthma and recurring wheezing, undergoing probiotic treatment with Bifiasthm with the aim of assessing the reduction in ast...
Detailed Description
Allergic disorders have dramatically increased in prevalence over the past decade, particularly in developed countries, and primary prevention of allergic disease has proved an elusive goal. There is ...
Eligibility Criteria
Inclusion
- The study will include all children aged 6 to 14, with slight and moderate persistent asthma according to GINA 2015 criteria (asthma classification did not change in GINA 2015 and 2016 guidelines), whether or not showing positive skin allergometric tests, as well as all children aged 2 yrs, 364 days to 5 years, 364 days, with recurring wheezing, whether or not diagnosed with asthma (positive and/or negative prick).
Exclusion
- Severe persistent asthma
- Known congenital or acquired immunodeficiencies
- Cystic fibrosis
- Chronic pulmonary diseases (bronchodysplasia)
- Age \< 1 yr, 364d and 14 yrs
Key Trial Info
Start Date :
April 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2019
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04289441
Start Date
April 21 2017
End Date
November 25 2019
Last Update
January 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Care Ambulatory
Pozzuoli, Naples, Italy, 80078